Schiff base complexes and their versatile applications as catalysts in oxidation of organic compounds: part I

Schiff bases and their complexes are good candidates as versatile compounds which are synthesized by the condensation of a primary amino compound with either aldehydes or ketones for a variety of industrial applications. They can act as catalysts in the catalytic oxidation of organic compounds. Recent researches in oxidation catalysis have focused on how to employ the metal‐catalyzed oxidation of organic substrates. This review summarizes the current developments of the last few decades for the oxidations of organic compounds that proceed through Schiff base complexes. The chemical syntheses of Schiff bases and their complexes are outlined.     

含半夹心铱/铑/钌结构基元的离散型金属环状化合物的研究进展

由于离散型金属环状化合物在主客体化学、气体吸附、分子识别及催化等领域被广泛应用,因此,构筑新型金属环状化合物并研究它们的物理化学性质及应用成为无机化学、有机化学和超分子化学中热门研究方向之一.具有半夹心结构的钌、铱和铑有机金属单元在形成金属环状化合物时具有以下的优势:增强了化合物的溶解性,屏蔽住金属的一半以减少反应的复杂性,易于修饰得到不同结构的产物.综述了近年来以半夹心结构的钌、铱和铑结构基元的离散型金属框架化合物的组装合成和应用.     

石英片基表面联吡啶钌配合物的合成与表征

将6-溴-2,2'∶6',2"-三联吡啶转化为6-甲酰基-2,2'∶6',2"-三联吡啶, 再将其与表面组装有氨基硅氧烷的石英片基反应, 使甲酰基与片基表面的氨基反应生成Schiff碱型化合物, 在氨基化片基表面成功地固定6-甲酰基-2,2'∶6',2"-三联吡啶及相应的钌配合物, 并用紫外-可见吸收光谱及光电子能谱(XPS)检测联吡啶及相应钌配合物的组装过程.     

DNA interaction and cytotoxicity studies of ruthenium(III) complexes containing 3-(benzothiazol-2-yliminomethyl)-naphthalen-2-ol ligand

A new Schiff base, 3-(benzothiazol-2-yliminomethyl)-naphthalen-2-ol, has been synthesized and characterized by elemental analysis, Fourier transform infrared spectroscopy (FT-IR), UV–vis, nuclear magnetic resonance, and single-crystal X-ray diffraction. Ruthenium(III) complexes of the Schiff base were synthesized and characterized by analytical and spectroscopic (FT-IR, UV–vis, and electron paramagnetic resonance) data as well as magnetic susceptibility measurements. DNA-binding properties of the ligand and its ruthenium(III) complexes have been investigated by electronic absorption spectroscopy. The three ruthenium(III) complexes were tested for DNA cleavage. Further in vitro study of the cytotoxity of the ligand and the complexes on human cervical cancer cell line and human laryngeal epithelial carcinoma cell line were carried out.     

环戊二烯基钌配合物催化的高选择性苯乙炔二聚反应

Transition metal vinylidene complexes (M=C=CHR) have attracted a great deal of attention in recent years as a new type of organometallic intermediates that may have unusual reactivity[1]. Their reactivity has been explored and their application to organic synthesis is developed[2]. Recent reports on the ruthenium-vinylidene complexes[3]suggest that the reaction of ruthenium-vinylidene complexes with a base generates the coordinatively unsaturated ruthenium acetylide species, which are involved in a number of catalytic and stoichiometric reactions of alkynes. For example,the coordinatively unsaturated ruthenium acetylide species C5Me5Ru(PPh3)-C≡CPh,formed from the reaction of the vinylidene complex C5Me5Ru(PPh3) (Cl)=C=CHPh with a base was reactive toward a variety of small molecules and active in catalytic dimerization of terminal alkynes[4]. The dimerization of terminal alkyne is an effective method of forming enynes, but its synthetic application in organic synthesis has been limited dueto low selectivity for dimeric products[5]. In this communication, we report that three ruthenium complexes were used as catalysts for the highly selective dimerization of phenylacetylene.     

Metal complexes of novel Schiff base derived from iron sandwiched organometallic and 4‐nitro‐1,2‐phenylenediamine: Synthesis,characterization, DFT studies,antimicrobial activities and molecular docking

The condensation of 2‐acetylferrocene with 4‐nitro‐1,2‐phenylenediamine in a 1:1 molar ratio, resulting in formation of a novel bi‐dentate organometallic Schiff base ligand (L), (2‐(1‐((2‐amino‐5‐nitrophenyl)imino)ethyl)cyclopenta‐2,4‐dien‐1‐yl)(cyclopenta‐2,4‐dien‐1‐yl)iron. Also, its Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) complexes have been synthesized. The stoichiometric ratios of the prepared compounds were estimated using elemental analysis (C, H, N, M), molar conductivity, FT‐IR, UV‐Vis, ¹H‐NMR, SEM and mass spectral analysis. Furthermore, their TG and DTG properties were studied. The geometrical structure of the complexes was found to be octahedral. From spectral analysis, the Schiff base coordinated to metal ions through the azomethine and amine groups. DFT‐based molecular orbital energy calculations of the synthesized ligand have been studied, in which the ligand was theoretically optimized. The Schiff base and its metal complexes have been screened for their antimicrobial activities against different bacterial and fungal species by using disc diffusion method. The anticancer activities of the ligand and its metal complexes have also been studied towards breast cancer (MCF‐7) and human normal melanocytes (HFB‐4) cell lines. Molecular docking was also used to identify the interaction between the Schiff base ligand and its Cd(II) complex with the active site of the receptors of breast cancer mutant oxidoreductase (PDB ID: 3HB5), crystal structure of Staphylococcus aureus (PDB ID: 3Q8U) and yeast‐specific serine/threonine protein phosphatase (PPZ1) of Candida albicans (PDB ID:5JPE).     

The Contribution of Ruthenium in the Development of Metallomesogens

Ruthenium remains one of the most popular metals in inorganic and organometallic chemistry. The multiple oxidation state that it possesses and the versatility in its coordination mode have contributed to this success. However, despite the facility to synthesize all kind of ruthenium-based complexes, the insertion of ruthenium in metallomesogens remains scarce. This review presents all metallomesogens incorporating ruthenium over the last 35 years, suggesting that the contribution of ruthenium in the development of metallomesogens has just begun.     

Organometallic ruthenium-based antitumor compounds with novel modes of action

Both metal complexes and organic molecules are widely used for the treatment of various diseases including cancer - in addition to surgery and radiotherapy. Recent years have witnessed a surge of interest in the application of organometallic compounds to treat cancer and other diseases. Indeed, the unique properties of organometallic compounds, intermediate between those of classical inorganic and organic materials provide new opportunities in medicinal chemistry. In this review, based on the award lecture at ICBOMC’10, we describe a class of ruthenium(II)-arene complexes that are weakly cytotoxic in vitro, but show selective antimetastatic activity in vivo. These compounds, [Ru(η⁶-p-arene)Cl₂(pta)] termed RAPTA, interact strongly with proteins, with the ability to discriminate binding to different proteins, but show a relatively low propensity to bind DNA, which is considered to be the main target of many metal-based drugs. The basic RAPTA structure is quite stable in physiological environments, and studies have shown that aquation of the chloride bonds occurs, it may not be an essential step for anticancer drug activity - direct substitution with biomolecular targets is also possible. Based on the favorable physicochemical properties of RAPTA compounds, combined with their highly promising pharmacological properties, the structure represents an ideal scaffold for rational drug design. Thus far, strategies to overcome drug resistance, by interference with critical enzymes responsible for drug deactivation, and tumor targeting, by tethering to human serum albumin via hydrolyzable linkers, have been demonstrated. However, many more approaches can be envisaged. In any case, the net result are a type of hybrid compounds, that occupy a niche somewhere between classical cisplatin-type anticancer agents that are widely applied to many tumor types and targeted therapies based on organic structures used to inhibit specific enzymes. As such, should these compounds prove themselves in the clinic it is not inconceivable that they could be rapidly refined to form personalized chemotherapies.     

Ruthenium complexes bearing bidentate Schiff base ligands as efficient catalysts for organic and polymer syntheses

A concise overview is given on mononuclear and dinuclear, bidentate Schiff base ruthenium complexes with different additional ligands and on their applications in various chemical transformations such as Kharasch addition, enol-ester synthesis, alkyne dimerization, olefin metathesis and atom transfer radical polymerization. These new ruthenium complexes, conveniently prepared from commonly available ruthenium compounds, are very stable, exhibit a good tolerance towards organic functionalities, air and moisture and display high activity and chemoselectivity in chemical transformations. Relevant features of coordination chemistry connected with the reaction mechanism and chemoselectivity are also fully described. Since the nature of Schiff bases can be changed in a variety of ways, appealing routes for designing and preparing novel ruthenium complexes can be foreseen in the future.     

Organometallic Syntheses with Diazoalkanes

In recent years, aliphatic diazo compounds have proved to be more and more versatile as reagents in the preparative chemistry of organometallic complexes. As readily accessible compounds, they are not only suitable for the synthesis of known kinds of metal complexes but also open fresh routes to novel complex systems. The comparatively new field of diazoalkane complex chemistry exhibits numerous unexpected and novel reactions, and introduces interesting and promising aspects into the chemistry of carbonylmetal compounds.     

2-羟基-1-萘甲醛缩邻苯二胺席夫碱及其铜(Ⅱ)配合物的合成及组成测定——介绍一个大学化学综合实验

设计开发了一个大学化学综合性实验,合成了2-羟基-1-萘甲醛缩邻苯二胺席夫碱及其铜(Ⅱ)配合物,分别采用化学分析法和仪器分析法对配合物的组成进行了测定,并结合红外光谱、核磁共振氢谱对产物的结构进行了表征,取得了满意的实验结果。该实验一定程度上弥补了大学化学教学实验中合成有机金属配位化合物教学资源的匮乏。通过该实验的实施,可使学生进一步巩固回流、纯化、离心等基本操作技能,掌握摩尔比法测定配合物配位数及稳定常数的原理和方法,同时掌握运用有机波谱技术推断和鉴定分子结构的方法。本实验有利于培养学生综合运用有机化学、无机化学、化学分析及仪器分析等知识解决具体问题的能力,同时有利于学生了解席夫碱及其金属配合物的性质、研究动态等,激发学生对科学研究的热情,培养学生系统的科学思维和研究能力。     

Some divalent metal(II) complexes of novel potentially tetradentate Schiff base N,N′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde: Synthesis,spectroscopic characterization and bioactivities

A novel tetradentate dianionic Schiff base ligand, N ,N ′‐bis(2‐carboxyphenylimine)‐2,5‐thiophenedicarboxaldhyde (H₂L) and some first row d‐transition metal chelates (Co(II), Cu(II), Ni(II) and Zn(II)) were synthesized and characterized using various physicochemical and spectroscopic methods. The spectroscopic data suggested that the parent Schiff base ligand coordinates through both deprotonated carboxylic oxygen and imine nitrogen atoms. The free Schiff base and its metal chelates were screened for their antimicrobial activities for various pathogenic bacteria and fungi using the agar well diffusion method. The antibacterial and antifungal activities of all the newly synthesized compounds are significant compared to the standard drugs ciprofloxacin and nystatin. The antioxidant activities of the compounds were determined by reduction of 1,1‐diphenyl‐2‐picrylhydrazyl and compared with that of vitamin C as a standard. DNA binding ability of the novel Schiff base and its complexes was investigated using absorption spectroscopy, fluorescence spectroscopy, viscosity measurements and thermal denaturation. The obtained results clearly demonstrate that the binding affinity with calf thymus DNA follows the order: Cu(II) complex > Ni(II) complex > Zn(II) complex > Co(II) complex >H₂L. Furthermore, the DNA cleavage activity of the newly synthesized ligand and its metal complexes was investigated using supercoiled plasmid DNA (pUC18) gel electrophoresis.     

Synthesis,characterization, and in vitro antioxidant and anticancer studies of ruthenium(III) complexes of symmetric and asymmetric tetradentate Schiff bases

Ruthenium(III) complexes of three tetradentate Schiff bases with N₂O₂ donors formulated as [RuCl(LL¹)(H₂O)], [RuCl(LL²)(H₂O)] and [RuCl(LL³)(H₂O)] were synthesized and characterized by elemental analyses, molar conductance, FTIR, and electronic spectral measurements. The FTIR data showed that the tetradentate Schiff base ligands coordinate to Ru ions through the azomethine nitrogen and enolic oxygen. The antioxidant activities of the complexes were investigated through scavenging activity on 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radicals. The DPPH activity for [RuCl(LL²)(H₂O)] with IC₅₀ = 0.031 mg mL^?1 was higher than the values obtained for the other Ru(III) compounds. The study revealed that the synthesized Ru(III) complexes of the tetradentate Schiff base exhibited strong scavenging activities against DPPH and moderate against ABTS radicals. In addition, the antiproliferative studies of the complexes were also tested against human renal cancer cells (TK10), human melanoma cancer cells (UACC62), and human breast cancer cells (MCF7) using the SRB assay. The results indicated that the Ru(III) complexes showed low anticancer activities against the tested human cancer cell lines.     

Synthesis and characterization of heteroleptic Schiff base transition metal complexes: a study of anticancer,antimicrobial, DNA cleavage and anti-TB activity

In search of effective bioactive compounds, we have synthesized the new Co(II), Ni(II), and Cu(II) complexes of the Schiff base derived from 8-formyl-7-hydroxy-4-methylcoumarin and 2-hydrazino benzothiazole and characterized by analytical, spectroscopic (IR, NMR, UV–vis, Mass), magnetic, powder X-ray diffraction data (PXRD) and TGA studies. Elemental analysis suggests the stoichiometry of the synthesized complexes and the solution electronic spectral study revealed the octahedral geometry of the compounds. Thermal analysis shows the presence of water molecule outside the coordination sphere and powder-XRD patterns have been studied to test the degree of crystallinity of the complexes and unit cell calculations were made. All the synthesized compounds were tested against human ovarian cancer cell line (PA-1). The synthesized metal complexes exhibited enhanced activity against the tested bacterial (Staphylococcus aureus and Escherichia Coli) and fungal strains (Candida albicans and Aspergillus fumigatus) as compared to free ligand (LH). The results of the DNA-cleavage activity suggest that the ligand and its metal complexes can cleave CT-DNA at different degrees. Further, anti-tuberculosis activity was done using microplate almar blue assay. Among all these synthesized compounds, the Cu(II) complex exhibits good cleaving ability compared to other newly synthesized metal complexes.     

Design of molecular ferromagnets

A large variety of molecular ferromagnets have been synthesized since the discovery of the first organic ferromagnets, including pure organic compounds, organometallic charge-transfer complexes, metal complex-organic radical compounds, and transition metal complexes coupled to organic radicals. Besides, there are many reports on the observation of ferromagnetism in polymers and organic matrix composites. Molecular ferromagnets have great potential in different areas of technology such as low frequency magnetic shielding, magnetic imaging, magneto-optics and information storage. We provide a brief review on the current strategies for the design of molecular (organic) ferromagnets. This includes exploiting the inherent advantages of molecular systems, such as the ability to fine-tune the properties at the molecular level, and to control dimensionality, supramolecular structuring and hierarchy of spin interactions etc. for carrying out structural modifications and chemical functionalisations of stable open-shell molecules in order to generate supramolecular structures in which the natural prediction for antiparallel spin alignment (antiferromagnetism) is avoided.     

Synthesis,spectral and antibacterial activity of Co(II), Ni(II) and Zn(II) complexes with 2‐hydroxy‐benzoic acid(3,4‐dihydro‐2H‐naphthalen‐1‐ylidene)‐hydrazide

A bioactive Schiff base HL i.e. 2‐hydroxy‐benzoic acid(3,4‐dihydro‐2H ‐naphthalen‐1‐ylidene)‐hydrazide was synthesized by reacting equimolar amount of salicylic acid hydrazide and 1‐tetralone. Co(II), Ni(II) and Zn(II) complexes of ligand HL was synthesized in 1:1 and 1:2 molar ratio of metal to ligand. The structure of the synthesized ligand and metal complexes was established by elemental analysis, molar conductance, magnetic susceptibility measurements, electronic, IR and EPR spectral techniques. For determining the thermal stability the TGA has been done. In DFT studies the geometries of Schiff bases and metal complexes were fully optimized with respect to the energy using the 6–31 + g(d,p) basis set. Spectral data reveal that ligand behave uninegative tridentate in ML complexes and uninegative bidentate in ML₂ complexes. On the basis of characterization octahedral geometry has been assigned for Co(II) and Ni(II) complexes, while tetrahedral for Zn(II) complexes. Antibacterial activity of the synthesized compounds were evaluated against Staphylococcus aureus , Bacillus subtilis, Escherichia coli , Xanthomonas campestris and Pseudomonas aeruginosa and the results revealed that metal complexes show enhanced activity in comparison to free ligand.     

Synthesis,characterization and coordination behavior of 2-(1-carboxyl-2-hydroxyphenyl)thiazolidine

The reaction of 3-formylsalicylic acid with 2-aminoethanethiol produces 2-(1-carboxyl-2-hydroxyphenyl)thiazolidine (H₂chptz) which remains in equilibrium in solution with its corresponding Schiff base, 3-carboxysalicylidenethioethanolimine (H₃mcsalim) having an NSO-donor set of atoms. The reactions of the thiazolidine ligand with different metal salts leading to the synthesis of many new metal complexes and organometallic derivatives have been studied. For all the complexes the dianion of the Schiff base, H₃mcsalim acts as a tridentate NSO donor ligand. The reactions of [(Hmcsalim)Ti(π-C₅H₅)Cl] and [(Hmcsalim)Sn(Me)Cl], isolated in this study, with Me₃SiE (where, E stands for SMe, NMe₂ and C≡CPh) have also been studied. The elemental analyses, magnetic susceptibilities, molar conductance values, EPR-study, CV, molecular weights and spectroscopic (UV-Vis, IR, ¹H NMR) data characterize all the compounds under study. Based upon these data the geometry of the compounds has also been proposed.     

New azo‐azomethine‐based transition metal complexes: Synthesis,spectroscopy, solid‐state structure,density functional theory calculations and anticancer studies

A novel tetradentate azo‐Schiff base ligand (H₂L) was synthesized by 2:1 molar condensation of an azo‐aldehyde and ethylenediamine. Its mononuclear Cu(II), Ni(II), Co(II) and Zn(II) complexes were prepared and their structures were confirmed using elemental analysis, NMR, infrared and UV–visible spectroscopies and molar conductivity measurements. The results suggest that the metal ion is bonded to the tetradentate ligand through phenolic oxygens and imine nitrogens of the ligand. The solid‐state structures of the azo‐Schiff base ligand and its Cu(II) complex were determined using single‐crystal X‐ray diffraction studies. The azo‐Schiff base ligand lies on a crystallographic inversion centre and thus the asymmetric unit contains half of the molecule. X‐ray data revealed that keto–amine tautomer is favoured in the solid‐state structure of the ligand. In the structure of the Cu(II) complex, the Cu(II) ion is coordinated to two phenolate oxygen atoms and two imine nitrogen atoms of the azo‐Schiff base ligand with approximate square planar geometry. The anticancer activity of the synthesized complexes was investigated for human cancer cell line (MCF‐7) and cytotoxicity of the synthesized compounds was determined against mouse fibroblast cells (L929). The ligand and its complexes were found to show antitumor activity. The synthesized metal complexes were optimized at the B3LYP/LANL2DZ level and a new theoretical formula for MCF‐7 cells was also derived.